T Cell News and Research

Latest T Cell News and Research

FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a supplemental new drug application for SUSTIVA (efavirenz), including dosing recommendations for HIV-1 infected pediatric patients three months to three years old and weighing at least 3.5 kg.

4 May 2013

Researchers issue statement regarding use of unproven stem cell therapies

An international group of leading stem cell researchers has issued a statement that specifies concerns about the development and use of unproven stem cell therapies.

4 May 2013

Virtual reality reveals new clues on how cells determine place

Leaving the house in the morning may seem simple, but with every move we make, our brains are working feverishly to create maps of the outside world that allow us to navigate and to remember where we are.

4 May 2013

Study: Stem cells can communicate with mature heart cells, form electrical couplings

Stem cells drawn from amniotic fluid show promise for tissue engineering, but it's important to know what they can and cannot do. A new study by researchers at Rice University and Texas Children's Hospital has shown that these stem cells can communicate with mature heart cells and form electrical couplings with each other similar to those found in heart tissue.

3 May 2013

Study reveals how the properties of embryonic stem cells are controlled

Scientists have made a fundamental discovery about how the properties of embryonic stem cells are controlled.

3 May 2013

Mesp1 gene plays a key role in the development of heart, blood and skeletal muscle

New research out of the Lillehei Heart Institute at the University of Minnesota shows that by turning on just a single gene, Mesp1, different cell types including the heart, blood and muscle can be created from stem cells.

3 May 2013

Newly discovered ‘master regulator’ gene may help develop novel treatment for drug-resistant tumors

Researchers at Johns Hopkins have identified a gene that, when repressed in tumor cells, puts a halt to cell growth and a range of processes needed for tumors to enlarge and spread to distant sites. The researchers hope that this so-called "master regulator" gene may be the key to developing a new treatment for tumors resistant to current drugs.

3 May 2013

Preclinical data of Emergent BioSolutions' ES414 in mCRPC presented at PEGS 2013

Emergent BioSolutions Inc. today announced that it presented preclinical data on its lead bispecific ADAPTIRTM (Modular Protein Technology) molecule, ES414, at the 9th Annual Protein and Antibody Engineering Summit, currently underway in Boston, MA.

3 May 2013

Study results may help introduce better preoperative treatment for breast cancer

Breast cancers contain many different cell types with different patterns of gene expression, but a new study provides reassurance that this variability should not be a barrier to using gene expression tests to help tailor cancer treatments to individual patients.

3 May 2013

Scientists spell out pivotal role of Peli1 in mouse model of multiple sclerosis

Scientists have identified an influential link in a chain of events that leads to autoimmune inflammation of the central nervous system in a mouse model of multiple sclerosis.

3 May 2013

EPAC2 and diabetes: an interview with Dr. Hussain, Johns Hopkins University

EPAC stands for exchange protein activated by cyclic AMP (cAMP). cAMP is an (among many) intracellular messenger molecule. cAMP is generated when certain hormones stimulate a cell by binding to their receptor, which is at the outside surface of the cell.

3 May 2013

Researchers describe alterations in long noncoding RNA sequences in Rett syndrome

Researchers at the Epigenetics and Cancer Biology Program at IDIBELL led by Manel Esteller, ICREA researcher and professor of genetics at the University of Barcelona, have described alterations in noncoding long chain RNA sequences in Rett syndrome.

3 May 2013

Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.

3 May 2013

Boehringer Ingelheim Pharmaceuticals, Eli Lilly launch SGLT disease education initiative

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the launch of an educational campaign designed to provide healthcare professionals with a greater understanding of the role sodium glucose co-transporters play in maintaining blood sugar balance, or glucose homeostasis.

3 May 2013

Study results support new view of molecules important for nerve cell signaling

National Institutes of Health researchers used the popular anti-wrinkle agent Botox to discover a new and important role for a group of molecules that nerve cells use to quickly send messages.

3 May 2013

UAB study evaluates crash risk for elderly drivers who always drive with pets

Senior drivers who always take a pet in the car are at increased risk for being involved in a motor vehicle collision, said University of Alabama at Birmingham researchers.

3 May 2013

Researchers reveal how Ebola evades human immune response

Researchers have discovered the mechanism behind one of the Ebola virus' most dangerous attributes: its ability to disarm the adaptive immune system.

3 May 2013

Measurement variation influences gene expression profiles of breast cancer

An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer.

3 May 2013

Men who take statins are less likely to die from prostate cancer, study finds

Men with prostate cancer who take cholesterol-lowering drugs called statins are significantly less likely to die from their cancer than men who don't take such medication, according to study led by researchers at Fred Hutchinson Cancer Research Center.

3 May 2013

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

Medical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism.

3 May 2013

T Cell News and Research

Latest T Cell News and Research

FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

Researchers issue statement regarding use of unproven stem cell therapies

Virtual reality reveals new clues on how cells determine place

Study: Stem cells can communicate with mature heart cells, form electrical couplings

Study reveals how the properties of embryonic stem cells are controlled

Mesp1 gene plays a key role in the development of heart, blood and skeletal muscle

Newly discovered ‘master regulator’ gene may help develop novel treatment for drug-resistant tumors

Preclinical data of Emergent BioSolutions' ES414 in mCRPC presented at PEGS 2013

Study results may help introduce better preoperative treatment for breast cancer

Scientists spell out pivotal role of Peli1 in mouse model of multiple sclerosis

EPAC2 and diabetes: an interview with Dr. Hussain, Johns Hopkins University

Researchers describe alterations in long noncoding RNA sequences in Rett syndrome

Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

Boehringer Ingelheim Pharmaceuticals, Eli Lilly launch SGLT disease education initiative

Study results support new view of molecules important for nerve cell signaling

UAB study evaluates crash risk for elderly drivers who always drive with pets

Researchers reveal how Ebola evades human immune response

Measurement variation influences gene expression profiles of breast cancer

Men who take statins are less likely to die from prostate cancer, study finds

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

Immunology eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in